These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20510817)

  • 21. Physician practice volume and alternative surgical treatment for breast cancer in Florida.
    Luther SL; Studnicki J
    Health Serv Res; 2001 Dec; 36(6 Pt 2):166-79. PubMed ID: 16148967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1998-1999 patterns of care study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of stage I-II breast cancer.
    Pierce LJ; Moughan J; White J; Winchester DP; Owen J; Wilson JF
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):183-92. PubMed ID: 15850920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Justification for lumpectomy in the treatment of breast cancer: a commentary on the underutilization of that procedure.
    Fisher B
    J Am Med Womens Assoc (1972); 1992; 47(5):169-73. PubMed ID: 1460221
    [No Abstract]   [Full Text] [Related]  

  • 24. Factors determining adequacy of axillary node dissection in breast cancer patients.
    Chagpar AB; Scoggins CR; Martin RC; Sahoo S; Carlson DJ; Laidley AL; El-Eid SE; McGlothin TQ; McMasters KM;
    Breast J; 2007; 13(3):233-7. PubMed ID: 17461896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and trends of surgical modalities for breast cancer in China: a review of 16-year data.
    Yu KD; Di GH; Wu J; Lu JS; Shen KW; Shen ZZ; Shao ZM
    Ann Surg Oncol; 2007 Sep; 14(9):2502-9. PubMed ID: 17564750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06.
    Fisher ER; Anderson S; Redmond C; Fisher B
    Semin Surg Oncol; 1992; 8(3):161-6. PubMed ID: 1496227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Too many mastectomies for early breast cancers.
    Harv Womens Health Watch; 1999 Oct; 7(2):7. PubMed ID: 10534792
    [No Abstract]   [Full Text] [Related]  

  • 28. Excision of high-risk breast lesions on needle biopsy: is there a standard of core?
    Lawton TJ; Georgian-Smith D
    AJR Am J Roentgenol; 2009 May; 192(5):W268. PubMed ID: 19380536
    [No Abstract]   [Full Text] [Related]  

  • 29. The importance of surgical margin control in breast-conserving therapy.
    Ziogas D; Xeropotamos N; Batsis C
    Ann Surg Oncol; 2008 Feb; 15(2):659-60. PubMed ID: 17932719
    [No Abstract]   [Full Text] [Related]  

  • 30. Cut costs and improve care, too? These doctors did.
    Slomski AJ
    Med Econ; 1990 Mar; 67(6):48-53. PubMed ID: 10104022
    [No Abstract]   [Full Text] [Related]  

  • 31. Compliance with breast-conservation standards for patients with early-stage breast carcinoma.
    White J; Morrow M; Moughan J; Owen J; Pajak T; DesHarnais S; Winchester DP; Wilson JF; ;
    Cancer; 2003 Feb; 97(4):893-904. PubMed ID: 12569588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicentricity in early breast cancer.
    Gump FE
    Semin Surg Oncol; 1992; 8(3):117-21. PubMed ID: 1496220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should we treat minimal breast cancer lesions?
    Ito Y
    Breast Cancer; 2012 Apr; 19(2):93-4. PubMed ID: 22203580
    [No Abstract]   [Full Text] [Related]  

  • 34. Minimizing local recurrence after breast conserving therapy using intraoperative shaved margins to determine pathologic tumor clearance.
    Camp ER; McAuliffe PF; Gilroy JS; Morris CG; Lind DS; Mendenhall NP; Copeland EM
    J Am Coll Surg; 2005 Dec; 201(6):855-61. PubMed ID: 16310688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiotherapy for invasive breast cancer in North America and Europe: results of a survey.
    Ceilley E; Jagsi R; Goldberg S; Grignon L; Kachnic L; Powell S; Taghian A
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):365-73. PubMed ID: 15667954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re: what do recent studies on lumpectomy cavity volume change imply for breast clinical target volumes?
    Prosnitz RG; Haffty BG
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1603; author reply 1603. PubMed ID: 19306759
    [No Abstract]   [Full Text] [Related]  

  • 37. Variation in the use of breast-conserving therapy for Medicare beneficiaries in Virginia: clinical, geographic, and hospital characteristics.
    Elward KS; Penberthy LT; Bear H; Swartz DM; Boudreau RM; Cook SS
    Clin Perform Qual Health Care; 1998; 6(2):63-9. PubMed ID: 10180123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis.
    Vicini FA; Kestin LL; Goldstein NS
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):722-30. PubMed ID: 15465188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast tumor recurrence following lumpectomy with and without breast irradiation: an overview of recent NSABP findings.
    Fisher B; Wickerham DL; Deutsch M; Anderson S; Redmond C; Fisher ER
    Semin Surg Oncol; 1992; 8(3):153-60. PubMed ID: 1496226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence.
    Olson TP; Harter J; Muñoz A; Mahvi DM; Breslin T
    Ann Surg Oncol; 2007 Oct; 14(10):2953-60. PubMed ID: 17674109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.